This study was design to assess clinical agitation, electroencephalogram (EEG) and autonomic cardiovascular activity changes in children during induction of anesthesia with sevoflurane compared with halothane using noninvasive recording of EEG, heart rate, and finger blood pressure.


Children aged 2-12 yr premedicated with midazolam were randomly assigned to one of three induction techniques: 7% sevoflurane in 100% O2 (group SevoRAPID); 2%, 4%, 6%, and 7% sevoflurane in 100% O2 (group SevoINCR); or 1%, 2%, 3%, and 3.5% halothane in 50% N2O-50% O2 (group HaloN2O). An additional group of children who received 7% sevoflurane in 50% N2O-50% O2 (group SevoN2O) was enrolled after completion of the study. Induction was videotaped. EEG, heart rate, and finger blood pressure were continuously recorded during induction until 5 min after tracheal intubation and analyzed in frequency domain using spectral analysis.


Agitation was more frequent when anesthesia was induced with 100% O2 compared to the mixture of oxygen and nitrous oxide. No seizures were recorded in any group. In the four groups, induction of anesthesia was associated with an increase in EEG total spectral power and a shift toward the low-frequency bands. Sharp slow waves were present on EEG tracings of the three sevoflurane groups, whereas slow waves and fast rhythms (spindles) were observed in the halothane group. Sevoflurane induced a greater withdrawal of parasympathetic activity than halothane and a transient relative increase in sympathetic vascular tone at loss of eyelash reflex.


Agitation observed during sevoflurane induction was not associated with seizures. Sevoflurane induction induced a marked inhibition of parasympathetic control of heart rate.

SEVOFLURANE has a pleasant, nonpungent odor with minimal respiratory irritability that makes it suitable for mask induction. Sevoflurane inductions have initially been performed by increments in inspiratory concentration, based on historical precedent with other volatile agents such as halothane. Because sevoflurane has a safer respiratory and cardiovascular profile than that of halothane, 1,2high inspired concentrations can be used to speed up loss of consciousness and to reduce a child's distress scores. 3,4However, agitation is not uncommon during induction of anesthesia with sevoflurane in children. 3,5Agitation is usually observed after loss of consciousness and consists of uncoordinated movements associated with mild to severe body and limb hypertonia. However, no study has evaluated the electroencephalogram (EEG) changes that may occur during induction of anesthesia with sevoflurane in children. Case reports have described clinical seizure-like activity in children during induction of anesthesia with high-dose sevoflurane, 6,7but EEG evidence of seizure has only been reported in one healthy child during anesthesia 8and in epileptic children. 9Such seizure-like activity has been described during enflurane anesthesia 10–13but not with halothane, even in epileptic children. 14 

In addition to behavioral changes, the early induction phase is associated with an increase in heart rate (HR) and systolic blood pressure (SBP) in approximately 30–50% of pediatric patients. 3,15,16This may result from changes in autonomic cardiovascular activity despite no sympathetic activation having been described in healthy volunteers anesthetized with sevoflurane. 17The autonomic cardiovascular activity may be evaluated noninvasively using continuous blood pressure (BP) and HR recordings. 18,19Sympathetic and parasympathetic autonomic inputs into the sinoatrial node contribute to the HR power spectrum in well-determined frequency ranges. Indeed, low-frequency (LF) HR baroreflex-mediated fluctuations reflect the interplay of parasympathetic and sympathetic tone, 20,21whereas fluctuations of high frequency (HF) coinciding with the respiratory frequency are mainly caused by parasympathetic drive. With regard to BP, the LF oscillations reflect the vascular sympathetic modulation, 22whereas HF fluctuations proceed from changes in cardiac output likely via  respiratory induced changes in HR and ventricular filling. 23 

This study was designed to evaluate EEG tracings and autonomic cardiovascular activity changes in children during induction of anesthesia with sevoflurane administered either by gradual increments or at a high concentration using halothane as the reference induction gas.

Patients and Study Design 

The study was approved by the Ethics Committee (Comité Consultatif pour la Protection des Personnes dans la Recherche Biomédicale, Saint-Antoine, France), and written informed consent was obtained from parents. Children with American Society of Anesthesiologists physical status I who were aged 2–12 yr and were scheduled for elective tonsillectomy were entered onto the study. They were randomly assigned to one of three induction techniques: rapid induction with 7% sevoflurane in 100% O2(group SevoRAPID); incremental induction with 2%, 4%, 6%, and 7% sevoflurane every 5 breaths in 100% O2(group SevoINCR); incremental induction with 1%, 2%, 3%, and 3.5% halothane every 5 breaths in a mixture of oxygen and nitrous oxide (50:50; group HaloN2O). All children were premedicated 15 min before induction with 0.5 mg/kg midazolam administered rec- tally (maximum dose, 10 mg). Children received no drug other than the volatile agent until completion of the study, i.e. , 5 min after placement of the tracheal tube. Mask induction was performed using an open circuit with a non-rebreathing valve at high fresh-gas flow (8 l/min) by the same two unblinded investigators (M. C. D. and V. P.). Expired gases and oxygen saturation were continuously recorded (Capnomac Ultima; Datex Instrument Corporation, Helsinki, Finland). Time to loss of eyelash reflex and time to obtain central pupils were recorded. In addition, the degree of airway obstruction and time to insert an oral airway, if required, were recorded. Ventilation was manually assisted beforetracheal intubation at a rate close to 20 breaths/min. Tracheal intubation was performed using a RAE cuffed tracheal tube after placement of the intravenous line, and just after visualization of pupils in central position. After placement of the tracheal tube, the lungs were mechanically ventilated with a tidal volume of 10 ml/kg at a rate of 20 breaths/min (Servo 900D; Siemens, Göteborg, Sweden), inspired concentration was reduced to obtain 1 minimum alveolar concentration (MAC) of alveolar gas according to age, 24,25and this expired concentration was maintained for 5 min. Surgery started after completion of the study.

Electroencephalogram and hemodynamic data (see Analysis of Data) were continuously recorded in awake children before anesthesia and during induction until 5 min after tracheal intubation. All data were analyzed at baseline before anesthesia, at time of loss of eyelash reflex, just before tracheal intubation, and 5 min after tracheal intubation when expired anesthetic concentration was equal to 1 MAC. After completion of the study, halothane was discontinued in the HaloN2Ogroup, and anesthesia was maintained with sevoflurane in 50% N2O in all children. Recordings were continued for an additional 5 min after switching from halothane to sevoflurane (1 MAC expired concentration) in the last six patients allocated to the HaloN2Ogroup.

The induction period until 5 min after placement of the tracheal tube was videotaped and reviewed by a blinded independent pediatric neurologist (M. L. M.) to assess clinical signs and duration of agitation phase. Only involuntary movements unrelated to mask placement or venous puncture and occurring before the time of tracheal intubation were analyzed. The presence of involuntary movements was scored on a three-point scale: 0 = absent, 1 = localized to upper body; and 2 = generalized. Time at the beginning and end of the agitation phase was recorded.

Additional Study Group 

An additional group of 10 patients was later enrolled after completion of the study in an open-label, nonrandomized arm. Patients in this group (SevoN2O) received 7% sevoflurane in a mixture of oxygen and nitrous oxide (50:50). These patients were subjected to similar inclusion criteria, were premedicated with midazolam, and the same EEG and hemodynamic data were recorded. This additional group was deemed necessary after completion of the study and analysis of data because EEG and cardiovascular profiles differed between the halothane group and the two sevoflurane groups. In the initial study design, nitrous oxide was used in the halothane group because it corresponded to an established clinical practice, whereas it was omitted in the two sevoflurane groups to evaluate only the effects of sevoflurane.

Analysis of EEG Data 

Electroencephalogram was continuously recorded by an experienced EEG technician on 16 channels using a rubber helmet containing 20 cream-filled cup electrodes placed according to the 10–20 international system (Micromed, Merignac, France). The helmet has a chin strap designed to keep the electrodes snug on the scalp. The EEG signal was acquired on a microcomputer (Compaq, Houston, TX) using the Brain-Quick program (system II, Micromed, Merignac, France) and stored on hard disk. Bandpass filters were set at 0.5–30 Hz, and amplifier sensitivity was 200 μV. 26EEG was analyzed in the frequency domain. 27Spectral analysis of EEG signal was performed using fast Fourier transformation (Acqknowledge v3.25; Biopac Systems, Inc., Santa Barbara, CA) on 5.12-s epochs 28from the C3–P3 leads. The following parameters were calculated 27: total spectral power (TSP), defined as the area under the curve of the spectrum (μV2); spectral edge frequency 95, defined as the frequency below which 95% of the EEG power is located; and median power frequency, defined as the frequency below which 50% of the EEG power is located. Spectral bands of 0–4 Hz (δ), 4–8 Hz (θ), 8–13 Hz (α), and 13–30 Hz (β) were analyzed, and the power of the spectral bands was calculated and expressed as percentage of TSP. The δ ratio (ratio of the power in the 8–30 Hz band to power in the 0–4 Hz band) was calculated. All EEGs were reviewed by an independent blinded pediatric neurologist to assess whether seizure-like activity was present.

Analysis of Autonomic Cardiovascular Activity 

Electrocardiograph measurements were taken with disposable electrodes attached to the thorax and placed to provide clear R waves and were connected to a Datex cardiocap II monitor (Datex Instrumentation Corp). Finger arterial pressure was monitored noninvasively by a Finapres device (model 2300; Ohmeda, Trappes, France). The cuff size (small or medium) was adapted to the child's finger circumference, and the cuff was fitted to the third finger of the right hand, which was passively maintained at heart level during the study. The details of data sampling and analysis have been described previously. 19The analog outputs of the Datex monitor and of the Finapres device were connected to an analog-to-digital converter to permit data acquisition, storage, and analysis using a microcomputer. BP and ECG signals were digitized (300 Hz) and processed by an algorithm based on feature extraction to detect and measure the characteristics of a BP cycle and an R wave (Acqknowledge v3.25; Biopac Systems, Inc.). SBP was extracted from the BP signal. A resampling rate of 10 Hz was chosen without interpolation, i.e. , SBP and HR values were replicated every 0.1 s until a new BP cycle or R wave occurred within a 0.1-s window. The evenly spaced sampling allowed direct spectral analysis using a fast Fourier transformed algorithm on a 512-point stationary time series. This corresponded to a period of 51.2 s at our sampling rate. Power of the HR or BP spectrum (ordinates) had units of (beats/min)2or (mmHg)2and was used for calculations and statistical analysis. The integration of the values of consecutive bands was computed to estimate the various components of the variability. The TSP was taken as the overall variability and was obtained by integration of all the spectral bands after exclusion of the first one. The LF component was obtained by integration of the values of six consecutive bands from 0.039 to 0.137 Hz of SBP or HR spectrum, to include the 10-s rhythm (0.1 Hz). The HF oscillation was obtained by integration of consecutive bands from 0.215 Hz to 0.703 Hz to include those corresponding to the spontaneous breathing rates of all children.

Statistical Analysis 

Data of the three randomized groups (HaloN2O, SevoRAPID, and SevoINCR) were analyzed after logarithmic transformation using analysis of variance for repeated measures followed by Scheffépost hoc  tests (Statview version 5.0; Abacus Concept, Inc., Berkeley, CA). Data of the additional group (SevoN2O) were compared after logarithmic transformation to those of the halothane group using analysis of variance for repeated measures followed by Scheffépost hoc  tests. The effects of switching halothane for sevoflurane on EEG parameters were studied using a paired t  test (six patients). Nominal data were compared using the chi-square test. P  values < 0.05 were considered significant. Data are expressed as mean ± SD.

Thirteen children were enrolled in the halothane group, 11 in SevoINCRand SevoRAPIDgroups, and 10 in the additional group (SevoN2O). The four groups were comparable with regard to age and weight (table 1). Loss of eyelash reflex occurred earlier in sevoflurane groups compared with the halothane group, but the time to obtain central pupils was not significantly different among the four groups. Most of the children required insertion of an oral airway within the first 3 min of induction to relieve partial airway obstruction. Airway obstruction was more frequently observed in the SevoN2Ogroup compared with the other groups. The airways of one child in the HaloN2Ogroup and 3 of 11 in the SevoINCRand SevoRAPIDgroups remained partly obstructed during the early induction phase despite insertion of the oral airway. Oxygen saturation was maintained at > 96% throughout the study in all children. In the four groups, respiratory frequency increased significantly at loss of eyelash reflex compared with control awake values (P < 0.001). No hypercapnia (defined as end-tidal carbon dioxide > 48 mmHg) was observed in any group.

Transient agitation was observed in 7 of 13 children in the HaloN2Ogroup compared with 10 of 11 in theSevoINCRand SevoRAPIDgroups (P = 0.04). Incidence of agitation was not different between the HaloN2Oand SevoN2Ogroups. Uncoordinated movements occurred a few seconds before loss of eyelash reflex, were generalized (score 2), and lasted on average < 1 min. No clinical signs of seizure were observed in any group.

EEG Data Analysis 

Complete EEG tracings were obtained in all patients; therefore, 45 recordings were analyzed. No seizure-like activity was recorded in any group. All calculated parameters changed significantly with time (P < 0.001). In the four groups, induction of anesthesia was associated with an increase in TSP and a shift toward the LF bands (table 2). At the time of loss of eyelash reflex, EEG patterns were different in sevoflurane groups compared with the halothane group: the slow waves (δ) were more prominent, whereas the fast rhythms (β) were less pronounced, as reflected by lower δ ratio and median power frequency during sevoflurane anesthesia compared with halothane. Spectral components were comparable during deep anesthesia (central pupils). During maintenance of anesthesia, 5 min after tracheal intubation, the differences between sevoflurane and halothane reappeared; the typical halothane tracing was composed of slow waves superimposed with fast rhythms (α+β) similar to barbiturate spindles, whereas typical sevoflurane tracing contained mainly sharp slow waves with very few fast rhythms (fig. 1). TSP tended to be higher under sevoflurane compared with halothane, but this increase reached statistical significance only when N2O was added in the additional group (SevoN2O).

In 6 of the 13 patients induced with halothane, EEG was further recorded 5 min after switching halothane (0.9%± 0.1% end tidal) for sevoflurane (2.5%± 0.2% end tidal) for maintenance of anesthesia. In these 6 children, EEG tracings changed rapidly after sevoflurane was introduced: TSP increased, whereas median power frequency and δ ratio decreased significantly compared with halothane at similar MAC values (P = 0.05, P = 0.001, and P < 0.001, respectively;fig. 2).

Hemodynamic Data Analysis 

Two patients were excluded for analysis of this part of the study: one in the HaloN2Ogroup for not obtaining accurate finger BP signal, and one in the SevoRAPIDgroup because baseline ECG showed supraventricular extrasystoles, thus preventing accurate spectral analysis. Therefore, 43 recordings of finger BP and HR were analyzed (12 in the HaloN2Ogroup, 11 in the SevoINCRgroup, 10 in the SevoRAPIDgroup, and 10 in the SevoN2Ogroup). Typical HR and SBP tracings and spectra are shown in fig. 3. All hemodynamic parameters (tables 3 and 4) changed significantly with time (P < 0.001).

Heart Rate. 

Mean level of HR was higher during induction of anesthesia with sevoflurane compared with halothane at all recorded times (table 3). No significant changes in HR were observed in the halothane group. In the sevoflurane groups, HR initially increased markedly, and maximal increase was, on average, 37 beats/min at loss of eyelash reflex. After this initial increase, HR decreased but remained higher than baseline values in the sevoflurane groups.

At baseline, children showed a high degree of HR variability as estimated by the TSP. Frequency domain analysis of this variability showed classical components, mainly assessed by the LF peak and the respiratory peak (HF) of the power spectra. In the four groups, induction of anesthesia was associated with a marked decrease in TSP, reflecting the loss of autonomic control on the sinus node. However, in sevoflurane groups, TSP and HF components were lower than in the halothane group. The LF/HF ratio increased at loss of eyelash reflex and 5 min after tracheal intubation with sevoflurane compared with halothane.

Arterial Pressure. 

Induction of anesthesia was associated with a comparable reduction in SBP in the four groups; this decrease in SBP was maximum before tracheal intubation (central pupils) and was equal to 24%, 21%, 28%, and 34% in the HaloN2O, SevoINCR, SevoRAPID, and SevoN2Ogroups, respectively (table 4).

At baseline, all children showed a similar SBP spectral profile in which the LF component accounted for approximately 60% of the overall variability. As expected, TSP was markedly reduced in the four groups during anesthesia. Five minutes after intubation, SBP spectra showed mainly HF peaks, accounting for > 80% of the overall variability and reflecting mechanical influence of controlled ventilation on SBP. These respiratory fluctuations were more pronounced in the two sevoflurane groups compared with the halothane group.

However, at loss of eyelash reflex, changes in SBP profiles were opposite: in the halothane group, the overall variability tended to decrease as expected with a reduction in LF component, whereas in sevoflurane groups, an increase in the overall variability associated with a increase of the LF component was observed.

Sevoflurane induction was associated with frequent transient clinical agitation and rapid EEG changes different from those observed with halothane, but clinical or electrical seizure activity was not evidenced in these children premedicated with midazolam. During sevoflurane induction, cardiovascular changes were characterized by a marked inhibition of parasympathetic control of HR together with a transient relative increase in sympathetic vascular tone.

Clinical Data 

Induction was more rapid with sevoflurane compared with halothane, especially when an initial high concentration of sevoflurane was used. These data are consistent with all previous reports. 3–5,29Time to loss of eyelash reflex was longer than that previously reported using sevoflurane in a mixture of oxygen and nitrous oxide, 30,31and this may be related to the high incidence of airway obstruction in this particular subgroup of patients, because most of the children had obstructive tonsils. Indeed, both halothane and sevoflurane are known to promote the collapse of the pharyngeal airway, leading to upper airway obstruction in children. ∥Transient agitation was more frequent when sevoflurane was administered with 100% O2compared with halothane or sevoflurane, both given in a mixture of oxygen and nitrous oxide. The addition of nitrous oxide seems to decrease the incidence of agitation during sevoflurane induction, as previously reported. 3,5Agitation was usually observed at time of loss of consciousness and lasted, on average, 1 min, whatever the agent used. Agitation consisted mainly of uncoordinated movements, including hypertonia of the upper body together with bending of lower and upper limbs, but no clinical signs of seizure activity were observed. Agitation occurred at the time of hemodynamic changes.

EEG Study 

Baseline EEGs were normal according to the children's age. Most tracings showed marked β activity predominantly in the frontal areas as a result from anesthetic premedication with midazolam. 32–34No seizure-like activity was recorded on the EEG tracings. Because midazolam has antiepileptic activity and is used for emergency treatment of seizures, 35,36the lack of evidence of seizure-like activity in our study may not apply to patients who are not premedicated. However, as previously mentioned, only case reports have described clinical seizure-like activity during induction or maintenance of anesthesia with high-dose sevoflurane 6–8and EEG patterns of seizures in epileptic children, 9although > 30 million patients had been anesthetized with sevoflurane by the end of 1998. EEG changes observed during halothane induction are consistent with those previously reported in adults and children. 37–42Basically, halothane anesthesia is associated with an increase in EEG TSP with a shift from low-voltage fast waves to high-voltage slow waves, together with a relative increase in the production of 14–30-Hz activity. This later β activity is mainly composed of fast rhythms similar to barbiturate spindles and is observed at 1 MAC halothane, whereas it decreases with increasing halothane concentration. 43The increase in δ power when end-tidal halothane concentration decreased from 2.3%± 0.4%(just before tracheal intubation) to 0.9%± 0.1%(5 min after intubation) in our study reflects the changes in the proportion of fast rhythms with decreasing halothane concentration. Changes in α and β activity seem to be the most useful bands for monitoring depth of halothane anesthesia. 40Conversely, during sevoflurane anesthesia, EEG changes are very similar with those observed with isoflurane or desflurane. 44Median power frequency decreases, whereas TSP and relative power in the δ and θ bands increase, and power in the β band decreases. 44–46No spindle-like activity can be evidence on the sevoflurane EEG tracings. At the three times of EEG analysis, tracings in the sevoflurane groups were very similar despite the fact that depth of anesthesia, as assessed by end-tidal anesthetic concentration, was different. This is in agreement with recent data that indicate that EEG parameters are useful indicators of depth of sedation with sevoflurane but bad predictors of movement after skin incision. 47EEG profile during anesthesia maintenance with sevoflurane is different from the one observed with halothane, as demonstrated by EEG changes observed in the same children when switching from halothane to sevoflurane (fig. 2), whereas less differences are observed at deeper anesthesia. This might reflect differential effect of volatile anesthetics on brain activity or different states of anesthesia, because sevoflurane has a much lower blood/gas partition coefficient than that of halothane, resulting in a faster blood and tissue uptake. These differences between sevoflurane and halothane have been observed whether or not sevoflurane was administered in oxygen or in a mixture of oxygen and nitrous oxide. It is known that the addition of N2O to a steady-state concentration of halothane or isoflurane decreases TSP and α- and β-range EEG power, whereas δ- and θ-range power increases. 41These changes may be different during anesthesia induction because steady state is not achieved.

Hemodynamic Study 

Heart Rate Profiles. 

Heart rate was basically unchanged during halothane induction, whereas it increased significantly in the sevoflurane groups. This increase was maximal at the time of loss of eyelash reflex. No differences in HR variability and profiles were observed between groups at baseline. All children were premedicated with midazolam. Midazolam decreases spectral components of HR variability but does not change the LF/HF ratio. 48Most anesthetic agents induce a dose-dependent inhibition of cardiac autonomic control, leading to a noticeable reduction of spontaneous fluctuations of HR. 49–51In the four groups, the decrease of overall HR variability during induction, as assessed by the TSP, is consistent with this autonomic inhibition. However, HR profiles during induction of anesthesia differed markedly between the sevoflurane groups and the halothane group. This has also been described by other investigators. 52Halothane anesthesia induces a decrease in LF and HF powers, suggesting that this agent alters both sympathetic and parasympathetic HR control. However, the respiratory-related parasympathetic modulation of HR seems to be relatively more preserved during halothane anesthesia compared with sevoflurane as assessed by the lower HF spectral powers. The relative preservation of vagal tone during halothane anesthesia has been previously reported in infants. 49Basically, induction with sevoflurane is associated with an abrupt increase in HR occurring around the time of loss of eyelash reflex. This marked HR acceleration is associated with a disappearance of respiratory sinus arrhythmia, assessed by HF fluctuations, which are primarily mediated by the parasympathetic system. Our results suggest that this early increase in HR, described in children, 3,16might result from a withdrawal of parasympathetic cardiac activity. In healthy adult volunteers who were not premedicated, administration of sevoflurane in doses ranging from 0.4 to 1.2 MAC was associated with stable HR without transient acceleration. 17,53,54This discrepancy between adult data and our present findings may result from the high level of parasympathetic tone observed in healthy children responsible for large vagally mediated respiratory sinus arrhythmia. Cardiac autonomic inhibition (sympathetic and parasympathetic) seems to be more profound with sevoflurane than with halothane, as evidenced by the lower LF and HF powers during maintenance of anesthesia.

Systolic Blood Pressure Profiles. 

Both halothane and sevoflurane induce an identical decrease in BP during induction of anesthesia. However, this decrease results from different mechanisms: both agents alter myocardial contractility, but the effects of sevoflurane are less pronounced than those of halothane, and sevoflurane decreases peripheral vascular resistances, whereas the latter remain unchanged with halothane. 1,2As expected, at baseline, overall variability of SBP was mainly caused by LF oscillations. However, respiratory fluctuations were important during spontaneous ventilation in all children, probably reflecting inspiratory efforts as a result of partial airway obstruction in premedicated children with hypertrophic tonsils. During anesthesia, a large decrease of the LF component was evidenced, reflecting a noticeable reduction of the nervous sympathetic activity. Sympathetic inhibition induced by general anesthetics has been extensively studied in human using a microneurographic technique. 17,55In healthy adult volunteers, sevoflurane seems to preserve nervous sympathetic traffic when up to 1.2 MAC is administered. However, in our study, sympathetic inhibition was observed at the time of tracheal intubation and was still present 5 min later when expired sevoflurane concentration was close to 1 MAC. The magnitude of respiratory SBP fluctuations is related to effective blood volume. 56The mechanical influence of standardized controlled ventilation on SBP was more pronounced in the two sevoflurane groups than in the halothane group despite unchanged blood volume, suggesting that vascular tonus was lower with sevoflurane compared with halothane. This is consistent with a more potent vasodilatatory effect of sevoflurane compared with halothane. 1 

An interesting finding is the SBP spectral differences between halothane and sevoflurane evidenced at the time of loss of eyelash reflex. In the halothane group, spectral profile of SBP was between awakening and deep-anesthesia profiles, reflecting progressive autonomic depression. Conversely, in the sevoflurane groups, spectral profile of SBP calculated at the time of loss of eyelash reflex showed a pattern close to that calculated at baseline. Moreover, overall variability (TSP), LF power, and HF power tended to increase compared with baseline, even if this increase reached statistical significance only when nitrous oxide was added. Although sympathetic activation has been demonstrated with desflurane or isoflurane, 17,55,57most studies have failed to demonstrate the same process with sevoflurane. However, an increase of norepinephrine during rapid induction with sevoflurane in a mixture of oxygen/nitrous oxide has been reported before tracheal intubation. 58Our results suggest that at loss of eyelash reflex, vascular nervous sympathetic activity may be maintained or increased with sevoflurane even in premedicated subjects.

Induction of anesthesia with halothane or sevoflurane is associated with marked changes in EEG activity and HR and SBP profiles in children. Agitation observed at the time of loss of eyelash reflex is more frequent when sevoflurane is administered with 100% O2compared with halothane or sevoflurane given in a mixture of nitrous oxide and oxygen. Agitation frequently observed during sevoflurane induction in our study was not associated with clinical or electrical seizure activity in children premedicated with midazolam. Except at a deep level of anesthesia, EEG profiles are different with the two agents; halothane tracings are composed of slow waves superimposed with spindles, whereas sevoflurane tracings mainly consist of sharp, slow waves. Sevoflurane markedly inhibits the parasympathetic control of HR and increases relatively transiently sympathetic vascular tone. This helps to explain the transient increase in HR and SBP often observed in children in the early induction phase.

Wodey E, Pladys P, Copin C, Lucas M, Chaumont A, Carre P, Lelong B, Azzis O, Ecoffey C: Comparative hemodynamic depression of sevoflurane versus halothane in infants. A NESTHESIOLOGY 1997; 87: 795–800
Holzman RS, Vandervelde ME, Kaus SJ, Body SC, Colan SD, Sullivan LJ, Soriano SG: Sevoflurane depresses myocardial contractility less than halothane during induction of anesthesia in children. A NESTHESIOLOGY 1996; 85: 1260–7
Dubois MC, Piat V, Constant I, Lamblin O, Murat I: Comparison of three techniques for induction of anaesthesia with sevoflurane in children. Paediatr Anaesth 1999; 9: 19–23
Baum V, Yemen T, Baum L: Immediate 8% sevoflurane induction in children: A comparison with incremental sevoflurane and incremental halothane. Anesth Analg 1997; 85: 313–6
Sarner JB, Levine M, Davis PJ, Lerman J, Cook DR, Motoyama EK: Clinical characteristics of sevoflurane in children: A comparison with halothane. A NESTHESIOLOGY 1995; 82: 38–46
Adachi M, Ikemoto Y, Kubo K, Takuma C: Seizure-like movements during induction of anaesthesia with sevoflurane. Br J Anaesth 1992; 68: 214–5
Bösenberg A: Convulsions and sevoflurane. Paediatr Anaesth 1997; 7: 477–8
Woodforth IJ, Hicks RG, Crawford MR, Stephen JP, Burke DJ: Electroencephalographic evidence of seizure activity under deep sevoflurane anesthesia in a nonepileptic patient. A NESTHESIOLOGY 1997; 87: 1579–82
Komatsu H, Taie S, Endo S, Fukuda K, Ueki M, Nogaya J, Ogli K: Electrical seizures during sevoflurane anesthesia in two pediatric patients with epilepsy. A NESTHESIOLOGY 1994; 81: 1535–7
Kurata J, Nakao S, Murakawa M, Adachi T, Shichino T, Mori K: The cerebral cortex origin of enflurane-induced generalized seizure in cats. Anesth Analg 1994; 79: 713–8
Stevens JE, Fujinaga M, Oshima E, Mori K: The biphasic pattern of the convulsive property of enflurane in cats. Br J Anaesth 1984; 56: 395–403
Fariello RG: Epileptogenic properties of enflurane and their clinical interpretation. Electroencephalogr Clin Neurophysiol 1980; 48: 595–8
Kruczek M, Albin MS, Wolf S, Bertoni JM: Postoperative seizure activity following enflurane anesthesia. A NESTHESIOLOGY 1980; 53: 175–6
Mecarelli O, De FM, Romanini L, Calvisi V, D'Andrea E: EEG and clinical features in epileptic children during halothane anaesthesia. Electroencephalogr Clin Neurophysiol 1981; 52: 486–9
Piat V, Dubois MC, Johanet S, Murat I: Induction and recovery characteristics and hemodynamic responses to sevoflurane and halothane in children. Anesth Analg 1994; 79: 840–4
Kern C, Erb T, Frei F: Haemodynamic responses to sevoflurane compared with halothane during inhalational induction in children. Paediatr Anaesth 1997; 7: 439–44
Ebert TJ, Muzi M, Lopatka CW: Neurocirculatory responses to sevoflurane in humans: A comparison to desflurane. A NESTHESIOLOGY 1995; 83: 88–95
Constant I, Girard A, Le Bidois J, Villain E, Laude D, Elghozi J: Spectral analysis of systolic blood pressure and heart rate after heart transplantation in children. Clin Sci 1995; 88: 95–102
Constant I, Villain E, Laude D, Girard A, Murat I, Elghozi J: Heart rate control of blood pressure variability in children: A study in subjects with fixed ventricular pacemaker rhythm. Clin Sci 1998; 95: 33–42
Akselrod S, Gordon D, Madwed J, Snidman N, Shannon DC, Cohen RJ: Hemodynamic regulation: Investigation by spectral analysis. Am J Physiol 1985; 249: H867–75
Pomeranz B, Macaulay RJ, Caudill MA, Kutz I, Adam D, Gordon D, Kilborn KM, Barger AC, Shannon DC, Cohen RJ: Assessment of autonomic function in humans by heart rate spectral analysis. Am J Physiol 1985; 248: H151–3
Pagani M, Montano N, Porta A, Malliani A, Abboud F, Birkett C, Somers V: Relationship between spectral components of cardiovascular variabilities and direct measures of sympathetic nerve activity in humans. Circulation 1997; 95: 1441–48
Saul JP, Berger RD, Albrecht P, Stein SP, Chen MH, Cohen RJ: Transfer function analysis of the circulation: Unique insights into cardiovascular regulation. Am J Physiol 1991; 261: H1231–45
Lerman J, Sikich N, Kleinman S, Yentis S: The pharmacology of sevoflurane in infants and children. A NESTHESIOLOGY 1994; 80: 814–24
Gregory G, Eger EI, Munson E: The relationship between age and halothane requirement in man. A NESTHESIOLOGY 1969; 30: 488–91
Rampil IJ: Elements of EEG signal processing. Int J Monit Comput 1987; 4: 85–98
Rampil IJ: A primer for EEG signal processing in anesthesia. A NESTHESIOLOGY 1998; 89: 980–1002
Levy W: Effect of epoch length on power spectrum analysis of the EEG. A NESTHESIOLOGY 1987; 66: 489–95
Agnor R, Sikich N, Lerman J: Single-breath vital capacity rapid inhalation induction in children. A NESTHESIOLOGY 1998; 89: 379–84
Meretoja OA, Taivainen T, Raiha L, Korpela R, Wirtavuori K: Sevoflurane-nitrous oxide or halothane-nitrous oxide for paediatric bronchoscopy and gastroscopy. Br J Anaesth 1996; 76: 767–71
Epstein RH, Stein AL, Marr AT, Lessin JB: High concentration versus incremental induction of anesthesia with sevoflurane in children: A comparison of induction times, vital signs, and complications. J Clin Anesth 1998; 10: 41–45
Greenblatt DJ, Ehrenberg BL, Gunderman J, Locniskar A, Scavone JM, Harmatz JS, Shader RI: Pharmacokinetic and electroencephalographic study of intravenous diazepam, midazolam, and placebo. Clin Pharmacol Ther 1989; 45: 356–65
Scott RC, Besag FM, Boyd SG, Berry D, Neville BG: Buccal absorption of midazolam: Pharmacokinetics and EEG pharmacodynamics. Epilepsia 1998; 39: 290–4
Veselis RA, Reinsel R, Alagesan R, Heino R, Bedford RF: The EEG as a monitor of midazolam amnesia: Changes in power and topography as a function of amnesic state. A NESTHESIOLOGY 1991; 74: 866–74
Yakinci C, Mungen B, Sahin S, Karabiber H, Durmaz Y: Midazolam in treatment of various types of seizures in children. Brain Dev 1997; 19: 571–2
Rivera R, Segnini M, Baltodano A, Perez V: Midazolam in the treatment of status epilepticus in children. Crit Care Med 1993; 21: 991–4
Avramov MN, Murayama T, Shingu K, Mori K: Electroencephalographic changes during vital capacity breath induction with halothane. Br J Anaesth 1991; 66: 212–5
Oshima E, Shingu K, Mori K: EEG activity during halothane anaesthesia in man. Br J Anaesth 1981; 53: 65–72
Sugiyama K, Joh S, Hirota Y, Kiyomitsu Y, Shibutani T, Niwa H, Matsuura H: Relationship between changes in power spectra of electroencephalograms and arterial halothane concentration in infants. Acta Anaesthesiol Scand 1989; 33: 670–5
Yli HA, Eskola H, Kaukinen S: EEG spectral power during halothane anaesthesia: A comparison of spectral bands in the monitoring of anaesthesia level. Acta Anaesthesiol Scand 1989; 33: 304–8
Yli HA: The effect of nitrous oxide on EEG spectral power during halothane and isoflurane anaesthesia. Acta Anaesthesiol Scand 1990; 34: 579–84
Lloyd TA, Cole PV, Prior PF: Quantitative EEG and brainstem auditory evoked potentials: Comparison of isoflurane with halothane using the cerebral function analysing monitor. Br J Anaesth 1990; 65: 306–12
Keifer JC, Baghdoyan HA, Lydic R: Pontine cholinergic mechanisms modulate the cortical electroencephalographic spindles of halothane anesthesia. A NESTHESIOLOGY 1996; 84: 945–54
Schwender D, Daunderer M, Mulzer S, Klasing S, Finsterer U, Peter K: Spectral edge frequency of the electroencephalogram to monitor “depth” of anaesthesia with isoflurane or propofol. Br J Anaesth 1996; 77: 179–84
Tatsumi K, Hirai K, Furuya H, Okuda T: Effects of sevoflurane on the middle latency auditory evoked response and the electroencephalographic power spectrum. Anesth Analg 1995; 80: 940–3
Power C, Crowe C, Higgins P, Moriarty D: Anaesthetic depth at induction: An evaluation using clinical eye signs and EEG polysomnography. Anaesthesia 1998; 53: 736–43
Katoh T, Suzuki A, Ikeda K: Electroencephalographic derivatives as a tool for predicting the depth of sedation and anesthesia induced by sevoflurane. A NESTHESIOLOGY 1998; 88: 642–50
Michaloudis D, Kochiadakis G, Georgopoulou G, Fraidakis O, Chlouverakis G, Petrou A, Pollard BJ: The influence of premedication on heart rate variability. Anaesthesia 1998; 53: 446–53
Oberlander TF, Berde CB, Saul JP: Halothane and cardiac autonomic control in infants: Assessment with quantitative respiratory sinus arrhythmia. Pediatr Res 1996; 40: 710–7
Kato M, Komatsu T, Kimura T, Sugiyama F, Nakashima K, Shimada Y: Spectral analysis of heart rate variability during isoflurane anesthesia. A NESTHESIOLOGY 1992; 77: 669–74
Galletly DC, Westenberg AM, Robinson BJ, Corfiatis T: Effect of halothane, isoflurane and fentanyl on spectral components of heart rate variability. Br J Anaesth 1994; 72: 177–80
Taguchi N, Watanabe S, Takeshima R, Nakayama H, Asakura N: Greater vagal depression during sevoflurane than halothane anesthesia (abstract). Anesth Analg 1997; 84: S457
Ebert TJ: Cardiovascular and autonomic effects of sevoflurane. Acta Anaesthesiol Belg 1996; 47: 15–21
Ebert TJ, Harkin CP, Muzi M: Cardiovascular responses to sevoflurane: A review. Anesth Analg 1995; 81: S11–22
Ebert TJ, Muzi M: Sympathetic hyperactivity during desflurane anesthesia in healthy volunteers: A comparison with isoflurane. A NESTHESIOLOGY 1993; 79: 444–53
Rooke GA, Schwid HA, Shapira Y: The effect of graded hemorrhage and intravascular volume replacement on systolic pressure variation in humans during mechanical and spontaneous ventilation. Anesth Analg 1995; 80: 925–32
Muzi M, Lopatka CW, Ebert TJ: Desflurane-mediated neurocirculatory activation in humans: Effects of concentration and rate of change on responses. A NESTHESIOLOGY 1996; 84: 1035–42
Nishiyama T, Aibiki M, Hanaoka K: Haemodynamic and catecholamine changes during rapid sevoflurane induction with tidal volume breathing. Can J Anaesth 1997; 44: 1066–70